Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm-A case-control study of coronary artery disease

Psychoneuroendocrinology

Volumn 36, Issue 1, 2011, Pages 139-143

  Szymanowski, A ^a   Nijm, J ^b   Kristenson, M ^a   Jonasson, L ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

Coronary artery disease; Cortisol; Matrix metalloproteinase; Stress

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; HYDROCORTISONE; INTERLEUKIN 6; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME REGULATION; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SALIVA LEVEL; SMOKING; STRESS;

AGED; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SALIVA; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 78649896531     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.06.012     Document Type: Article

References (23)

1. van den Akker E.L.T., Koper J.W., van Rossum E.F.C., Dekker M.J.H., Russcher H., de Jong F.H., Uitterlinden A.G., Hofman A., Pols H.A., Witteman J.C., Lamberts S.W. Glucocorticoid receptor gene and risk of cardivascular disease. Arch. Intern. Med. 2008, 168:33-39.
2. Aljada A., Ghanim H., Mohanty P., Hofmeyer D., Tripathy D., Dandona P. Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J. Clin. Endocrinol. Metab. 2001, 86:5988-5991.
3. Bhattacharyya M.R., Molloy G.J., Steptoe A. Depression is associated with flatter cortisol rhythms in patients with coronary artery disease. J. Psychosom. Res. 2008, 65:107-113.
4. Blankenberg S., Rupprecht H.J., Poirier O., Bickel C., Smieja M., Hafner G., Meyer J., Cambien F., Tiret L. Plasma concentrations and genetic variation of matrix metalloprotenase 9 and prognosis of patients with cardiovascular disease. Circulation 2003, 107:1579-1585. AtheroGene Investigators.
5. Chikanza I.C., Petrou P., Kingsley G., Chrousos G., Panayi G.S. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 1992, 35:1281-1288.
6. Dekker M.J.H.J., Koper J.W., van Aken M.O., Pois H.A.P., Hofman A., de Jong F.H., Kirschbaum C., Witteman J.C.M., Lamberts S.W.J., Tiemeier A. Salivary cortisol is related to atherosclerosis of carotid arteries. J. Clin. Endocrinol. Metab. 2008, 93:3741-3747.
7. Fantidis P., Perez De Prada T., Fernandez-Ortiz A., Carcia-Touchard A., Alfonso M., Sabaté M., Hernández R., Escaned J., Bauelos C., Macaya C. Morning cortisol production in coronary heart disease patients. Eur. J. Invest. 2002, 32:304-308.
8. Fukuda D., Shimada K., Tanaka A., Kusuyama T., Yamashita H., Ehara S., Nakamura Y., Kawarabayashi T., Iida H., Yoshiyama M., Yoshikawa J. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am. J. Cardiol. 2006, 97:175-180.
9. Förster C., Kahles T., Kietz S., Drenckhahn D. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line. J. Physiol. 2007, 580:937-949.
10. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 2002, 90:251-262.
11. Hamer M., OóDonnell K., Lahiri A., Steptoe A. Salivary cortisol responses to mental stress are associated with coronary artery calcification in healthy men and women. Eur. Heart. J. 2010, 31:424-429.
12. Harkness K.A., Adamson P., Sussman J.D., Davies-Jones G.A., Greenwood J., Woodroofe M.N. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 2000, 123:698-709.
13. Jefferis B.J., Whincup P., Welsh P., Wannamethee G., Rumley A., Lennon L., Thomson A., Lawlor D., Carson C., Ebrahim S., Lowe G. Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis 2010, 208:557-563.
14. Kai H., Ikeda H., Yasukawa H., Kai M., Seki Y., Kuwahara F., Ueno T., Sugi K., Imaizumi T. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 1998, 32:368-372.
15. Matthews K., Schwartz J., Cohen S., Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom. Med. 2006, 68:657-661.
16. Nijm J., Kristenson M., Olsson A.G., Jonasson L. Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity. J. Intern. Med. 2007, 262:375-384.
17. Steensberg A. The role of IL-6 in xercise-induced immune changes and metabolism. Exerc. Immunol. Rev. 2003, 9:40-47.
18. Strike P.C., Steptoe A. Behavioural and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom. Med. 2005, 67:179-186.
19. Särndahl E., Nijm J., Bergström I., Perretti M., Jonasson L. Enhanced neutrophil expression of annexin-1 in coronary artery disease. Metabolism 2010, 59:433-440.
20. Tayebjee M.H., Lip G.Y., Tan K.T., Patel J.V., Hughes E.A., MacFadyen R.J. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am. J. Cardiol. 2005, 96:339-345.
21. Walker B.R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 2007, 157:545-559.
22. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 2002, 20:125-163.
23. Zhang Y., McCluskey K., Fujii K., Wahl L.M. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J. Immunol. 1998, 161:3071-3076.